Zhenqian Huang

The Key Laboratory Of Advanced Interdisciplinary Studies
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

IFI27 and BAX are Essential for GSDME-Mediated Myeloma Cell Pyroptosis.

IFI27 and BAX are Essential for GSDME-Mediated Myeloma Cell Pyroptosis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 01, 2026

Downregulation of IL16 Expression Induces Chemotherapeutic Drug Sensitivity via Increased Degradation of Mutant TP53 in Acute Myeloid Leukemia Cells.

Downregulation of IL16 Expression Induces Chemotherapeutic Drug Sensitivity via Increased Degradation of Mutant TP53 in Acute Myeloid Leukemia Cells.

Journal: Balkan medical journal

Published: April 09, 2026

Chinese guidelines on comprehensive assessment of clinical practice in hematopoietic stem cell transplantation Δ.

Chinese guidelines on comprehensive assessment of clinical practice in hematopoietic stem cell transplantation Δ.

Journal: Journal of cancer research and therapeutics

Published: December 02, 2025

Daratumumab-based first-line therapy benefit multiple myeloma patients in a real-world setting: a multi-center retrospective propensity score-match study.

Daratumumab-based first-line therapy benefit multiple myeloma patients in a real-world setting: a multi-center retrospective propensity score-match study.

Journal: Annals of hematology

Published: September 09, 2025

FOXO3 upregulates and activates GSDME to trigger myeloma cell pyroptosis.

FOXO3 upregulates and activates GSDME to trigger myeloma cell pyroptosis.

Journal: International journal of biological sciences

Published: September 06, 2025

DIA Regimen Versus IA Regimen for Induction Therapy in Younger Adults With Acute Myeloid Leukemia: A Multicenter Open-Label Randomized Controlled Trial.

DIA Regimen Versus IA Regimen for Induction Therapy in Younger Adults With Acute Myeloid Leukemia: A Multicenter Open-Label Randomized Controlled Trial.

Journal: American journal of hematology

Published: July 12, 2025

Acevaltrate overcomes myeloma resistance to bortezomib via pyroptosis by promoting BAX translocalization to mitochondria.

Acevaltrate overcomes myeloma resistance to bortezomib via pyroptosis by promoting BAX translocalization to mitochondria.

Journal: European journal of pharmacology

Published: January 20, 2025

RNF6 Inhibits Lung Adenocarcinoma Cell Proliferation by Promoting Cyclin D2 Degradation.

RNF6 Inhibits Lung Adenocarcinoma Cell Proliferation by Promoting Cyclin D2 Degradation.

Journal: Molecular cancer research : MCR

Published: July 23, 2024

Sphingosine kinase 1 counteracts chemosensitivity and immune evasion in diffuse large B cell lymphoma cells via the PI3K/AKT/PD-L1 axis.

Sphingosine kinase 1 counteracts chemosensitivity and immune evasion in diffuse large B cell lymphoma cells via the PI3K/AKT/PD-L1 axis.

Journal: International immunopharmacology

Published: June 02, 2024

Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma.

Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma.

Journal: Signal transduction and targeted therapy

Published: November 19, 2023

Venetoclax plus a hypomethylating agent versus cytarabine, aclarubicin, and granulocyte colony-stimulating factor chemotherapy as a first-line therapy for newly diagnosed acute myeloid leukemia: A propensity score-matched analysis.

Venetoclax plus a hypomethylating agent versus cytarabine, aclarubicin, and granulocyte colony-stimulating factor chemotherapy as a first-line therapy for newly diagnosed acute myeloid leukemia: A propensity score-matched analysis.

Journal: Cancer

Published: November 11, 2023

Induction of IFIT1/IFIT3 and inhibition of Bcl-2 orchestrate the treatment of myeloma and leukemia via pyroptosis.

Induction of IFIT1/IFIT3 and inhibition of Bcl-2 orchestrate the treatment of myeloma and leukemia via pyroptosis.

Journal: Cancer letters

Published: November 09, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026